By Josh White
Date: Tuesday 12 Aug 2025
(Sharecast News) - Ixico has secured two new clinical trial contracts in neurological disorders with a combined value of about £1.3m, it announced on Friday, extending its presence in both Alzheimer's disease and rare central nervous system conditions.
By Josh White
Date: Thursday 17 Jul 2025
(Sharecast News) - Ixico said in an update on Thursday that it expects revenue for the financial year ending 30 September to be at least £6.3m, ahead of market expectations and representing a 9% increase from the prior year.
By Josh White
Date: Wednesday 12 Feb 2025
(Sharecast News) - Ixico announced further validation of its AI-driven imaging platform IXIQ.Ai in Huntington's disease (HD) research on Wednesday, through its collaboration with the Huntington's Disease Imaging Harmonisation (HD-IH) consortium.
Currency | UK Pounds |
Share Price | 12.25p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 13.00p |
52 Week Low | 7.75p |
Volume | 8,256 |
Shares Issued | 92.67m |
Market Cap | £11.35m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
11:06 | 8,212 @ 12.01p |
11:01 | 10 @ 12.01p |
11:00 | 10 @ 12.00p |
11:00 | 10 @ 12.00p |
09:03 | 16 @ 12.40p |
You are here: research